JoelNSaltzmanMD
Oncology • Mayfield Heights, OHGastrointestinal Cancer, Genitourinary Oncology, Hematologic Oncology
Assistant Professor, Medicine, Case Western Reserve University School of Medicine
Dr. Saltzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6780 Mayfield road
Mayfield Heights, OH 44124Phone+1 440-312-4569Fax+1 440-312-6687
Summary
- Dr. Joel Saltzman is an oncologist in Mayfield Heights, OH and is affiliated with multiple hospitals in the area, including Hillcrest Hospital and CLeveland Clinic. He received his medical degree from Ohio State University College of Medicine and has been in practice 20 years. He specializes in gastrointestinal cancer, genitourinary oncology, and hematologic oncology and is experienced in neuro-oncology, amyloidosis, hematologic oncology, breast cancer, and prostate cancer.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1997 - 2000
Ohio State University College of MedicineClass of 1997
Certifications & Licensure
OH State Medical License 1998 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
- Top MD Consumers Checkbook
Clinical Trials
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission Start of enrollment: 2010 Jul 01
- Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Publications & Presentations
PubMed
- 7 citationsPhase Ib/II study of Cetuximab Plus Pembrolizumab in Patients with Advanced RAS wild-type Colorectal Cancer.Christos Fountzilas, David L. Bajor, Sarbajit Mukherjee, Joel N. Saltzman, Agnieszka K. Witkiewicz
Clinical Cancer Research. 2021-10-13 - 43 citationsPemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non–Small-Cell Lung Cancer: ECOG-ACRIN 5508Suresh S. Ramalingam, Suzanne E. Dahlberg, Chandra P. Belani, Joel N. Saltzman, Nathan A. Pennell
Journal of Clinical Oncology. 2019-07-30 - 9 citationsA nationwide analysis of pancreatic cancer trial enrollment reveals disparities and participation problems.Jonathan J. Hue, Erryk Katayama, Sarah C. Markt, Mohamedraed Elshami, Joel N. Saltzman
Surgery. 2021-11-26
Press Mentions
New Therapy Gives Hope to Dementia Patients, Their Families and CaregiversJuly 16th, 2021- Determining Which Clinical Trial Is Best for YouJuly 16th, 2021
- New Technology Uses Genetic Testing to Help Millions Find the Perfect Clinical Trial MatchJuly 12th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
